REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $714,434 | +70.6% | 7,007 | +52.1% | 0.04% | +46.2% |
| Q1 2023 | $418,778 | +64.2% | 4,606 | +81.9% | 0.03% | +188.9% |
| Q3 2021 | $255,000 | -34.8% | 2,532 | -8.4% | 0.01% | -30.8% |
| Q2 2021 | $391,000 | +73.0% | 2,763 | +51.4% | 0.01% | +30.0% |
| Q4 2020 | $226,000 | -26.1% | 1,825 | -6.9% | 0.01% | -41.2% |
| Q2 2020 | $306,000 | +1.7% | 1,960 | -6.1% | 0.02% | -26.1% |
| Q1 2020 | $301,000 | -36.2% | 2,087 | -9.6% | 0.02% | +9.5% |
| Q4 2019 | $472,000 | +60.5% | 2,308 | -35.7% | 0.02% | +90.9% |
| Q3 2018 | $294,000 | – | 3,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |